309 related articles for article (PubMed ID: 7829790)
1. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Feb; 25(2):370-7. PubMed ID: 7829790
[TBL] [Abstract][Full Text] [Related]
2. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Jul; 26(1):66-72. PubMed ID: 7797777
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial.
Nunn CM; O'Neill WW; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Grines L; Browne KF; Vlietstra RE; Catlin T; Grines CL
J Am Coll Cardiol; 1999 Mar; 33(3):640-6. PubMed ID: 10080463
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
Stone GW; Grines CL; Rothbaum D; Browne KF; O'Keefe J; Overlie PA; Donohue BC; Chelliah N; Vlietstra R; Catlin T; O'Neill WW
J Am Coll Cardiol; 1997 Apr; 29(5):901-7. PubMed ID: 9120173
[TBL] [Abstract][Full Text] [Related]
5. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
6. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
[TBL] [Abstract][Full Text] [Related]
8. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
[TBL] [Abstract][Full Text] [Related]
9. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
Am J Cardiol; 1995 May; 75(15):987-92. PubMed ID: 7747700
[TBL] [Abstract][Full Text] [Related]
13. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
14. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators.
Bowers TR; Terrien EF; O'Neill WW; Sachs D; Grines CL
Am J Cardiol; 1996 Sep; 78(5):511-5. PubMed ID: 8806333
[TBL] [Abstract][Full Text] [Related]
15. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Am J Cardiol; 1996 Jul; 78(1):19-25. PubMed ID: 8712112
[TBL] [Abstract][Full Text] [Related]
16. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study.
Ribichini F; Steffenino G; Dellavalle A; Ferrero V; Vado A; Feola M; Uslenghi E
J Am Coll Cardiol; 1998 Nov; 32(6):1687-94. PubMed ID: 9822097
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
Califf RM; Topol EJ; Stack RS; Ellis SG; George BS; Kereiakes DJ; Samaha JK; Worley SJ; Anderson JL; Harrelson-Woodlief L
Circulation; 1991 May; 83(5):1543-56. PubMed ID: 1902405
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
19. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
Cucherat M; Bonnefoy E; Tremeau G
Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812
[TBL] [Abstract][Full Text] [Related]
20. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
Cucherat M; Bonnefoy E; Tremeau G
Cochrane Database Syst Rev; 2003; (3):CD001560. PubMed ID: 12917910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
